Impact of temporary and involuntary suppression of hydroxyurea treatment on hematological and clinical parameters in patients with sickle cell disease . RSD [Internet]. 2024 Jan. 6 [cited 2025 Jun. 28];13(1):e3013144727. Available from: https://ojs34.rsdjournal.org/index.php/rsd/article/view/44727